---
title: "Comparison of Administration of 8-Milligram and 4-Milligram Intranasal Naloxone by Law Enforcement During Response to Suspected Opioid Overdose - New York, March 2022-August 2023"
source_url: "https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=742802"
source_layer: us_cdc_mmwr
category: surveillance_summary
date: 2024-02-08
confidence: 中
mmwr_volume: ""
mmwr_issue: ""
---

## 摘要

This report describes real-world comparisons of survival, the average number of doses administered, the presence of postnaloxone signs and symptoms, and hospital transport refusal among people receiving 8-mg and 4-mg intranasal naloxone.

## 詳細內容

This report describes real-world comparisons of survival, the average number of doses administered, the presence of postnaloxone signs and symptoms, and hospital transport refusal among people receiving 8-mg and 4-mg intranasal naloxone.

## 關鍵發現

(需要透過 WebFetch 補充或人工審核來提取關鍵發現)

---
*萃取時間: 2026-02-05T15:10:12Z*
*資料來源: CDC MMWR*
